Metabolic Effects of Mealtime Insulin Lispro in Comparison to Glibenclamide in Early Type 2 Diabetes
Year: 2003
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1055/s-2003-39237
Authors: T. Forst, J. Eriksson, H.-J. Strotmann, S. Bai, R. Brunelle, K. Gulliya, S. Gack, U. Gudat
Institution: Eli Lilly (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2063922073